DrugsControl Media Services

News Detail

MIV-711 not associated with pain reduction, but may reduce disease progression in osteoarthritis (02-01-2020)

Leeds, UK, 30 Dec 2019: MIV-711, a novel selective cathepsin K inhibitor, was not more effective than placebo for reducing pain related to knee osteoarthritis. However, MIV-711 significantly reduced bone and cartilage progression. Findings from a randomized, placebo-controlled st......
View Details

Source : EurekAlert

Related News